Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_assertion type Assertion NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_head.
- NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_assertion description "[These technologies have aided in the advancement of cancer vaccine development, as illustrated in examples including NY-ESO-1 originally defined by SEREX, and HER2/neu peptides analyzed via high-throughput epitope prediction methods.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_provenance.
- NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_assertion evidence source_evidence_literature NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_provenance.
- NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_assertion SIO_000772 21732821 NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_provenance.
- NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_assertion wasDerivedFrom befree-20150227 NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_provenance.
- NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_assertion wasGeneratedBy ECO_0000203 NP981202.RAdnKxAbbXdDTtWHmfhVXSGBFDoy9IFdRKaCqnYOYmvp8130_provenance.